
Alveolar adenoma with a single cyst: A case report
- Authors:
- Published online on: February 16, 2024 https://doi.org/10.3892/mi.2024.140
- Article Number: 16
-
Copyright : © Matsui et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Abstract
Introduction
Alveolar adenoma (AA) is an exceedingly rare benign lung tumor that was first reported by Yousem et al in 1986(1). Patients with AA are usually asymptomatic and the tumor is incidentally detected on chest radiography as a clear solitary pulmonary nodule. When solid pulmonary nodules are >10 mm in size, there is an increased likelihood of surgical intervention due to a higher risk of malignancy and patient anxiety (2,3). A definitive diagnosis of AA depends on histopathology and immunohistochemistry findings as it is difficult to diagnose pre-operatively. Curative treatment consists of surgical resection, with no case of recurrence having been described to date in the literature, at least to the best of our knowledge.
The present study describes the case of a patient with alveolar adenoma and reports on the imaging and pathological differentiation of AA from other lung tumors.
Case report
A 50-year-old male patient presented to his previous doctor with a complaint of chest discomfort. A chest computed tomography (CT) scan revealed a 10-mm solitary nodule with a single cyst in the left lower lobe. The diameter of the pulmonary nodule increased to 14 mm within a span of 2 years (CT scan results shown in Fig. 1). He was referred to Kansai Medical University Hospital (Hirakata, Japan) due to the possibility of lung cancer. His medical history was notable for benign prostatic hyperplasia. A thoracoscopic wedge resection of the left lower lung was performed. The frozen sections were non-diagnostic, and the surgical procedure and postoperative course were uneventful, with no signs of recurrence 4 years post-operatively.
Overall, the tumor was well-defined and yellowish, measuring 10 mm in a subpleural cyst. Microscopically, the tumor consisted of polycystic structures resembling alveoli filled with pulmonary surfactant. The cyst lining cells were positive for thyroid transcription factor-1 (TTF-1) without atypia, corresponding to type II pneumocytes (Fig. 2). Additionally, the stroma lacked elastic fibers characteristic of alveoli and contained cluster of differentiation 34 (CD34)-positive cells with rounded nuclei and eosinophilic cytoplasm. These cells were negative for TTF-1, CD31, ERG, D2-40, SALL4, BRAF and STAT6. Immunohistochemical analysis was conducted on 4-µm-thick formalin-fixed paraffin-embedded tissue sections (details presented in Table I). Cultures were negative for fungi and tuberculosis, and no malignant cells were noted. Analyses were performed under a light microscope (Olympus Corporation) and whole slide images. Therefore, the final pathological diagnosis was that of AA.
Discussion
AA is a rare lung tumor with an incidence rate of <1% of all lung tumors, and is classified as an adenoma in the 2015 World Health Organization Classification of lung tumors (4). AA is often asymptomatic and is incidentally detected during imaging examinations, typically exhibiting no tendency to enlarge (5). The majority of patients are middle-aged to elderly, with a slight predominance in the female sex. There is no association between the occurrence of AA and a previous medical history or family history. AA commonly occurs in the middle and lower lobes of the lung and is pathologically characterized by multifocal cystic lesions resembling alveolar cavities, with the lumen lined by TTF-1-positive type II alveolar epithelium (6). In the present study, upon an examination of the patient, it was found that the tumor had similar histopathological features to the cases reported in the literature (6-11).
AAs are characterized by the presence of vacuoles within or around the tumor on imaging (7). It is speculated that alveoli rupture and fuse to create cavities, similar to the cavity formation mechanism observed in lung cancer. This occurs as tumor cells develop toward the bronchiole, forming a unidirectional check-valve system, which results in the accumulation of gas in the alveoli. This phenomenon may explain the cystic lesions observed in the pathology. Therefore, it is important to consider AA as a differential diagnosis in cases of pulmonary nodules with air images. In the case presented herein, the tumor increased in size with the presence of air images, highlighting the necessity to distinguish the tumor from lung cancer or pulmonary aspergilloma.
The diagnosis of AA is challenging when based on small biopsy tissue or frozen sections as it can resemble normal lung parenchyma or mimic malignancy with small glandular spaces lined by regular glandular epithelium (8). Additionally, there are other conditions in the differential diagnosis of AA, including papillary adenoma, sclerosing pneumocytoma and pulmonary hamartoma. Papillary adenoma is characterized by distinctive papillae covered by uniform cuboidal to columnar cells and a heterogeneous epithelial component. The presence of TTF-1 expression in AA can help distinguish it from sclerosing pneumocytoma. Pulmonary hamartoma consists primarily of benign cartilage mixed with a fibrovascular stroma and scattered bronchial glands (9).
The curative treatment for AA is surgical resection, typically performed to rule out malignancy and confirm the diagnosis through postoperative pathology. No recurrence has been reported following complete resection (10). In the case described herein, surgery was concluded with a wedge resection as the tumor was a peripheral lesion that could be completely resected, and the frozen section did not provide a definitive diagnosis. There is a risk of unnecessary extended resection, such as segmentectomy or lobectomy, if the patient is intraoperatively misdiagnosed with lung cancer based in the frozen section; hence, wedge resection is a viable option for small peripheral lesions (11).
In conclusion, AA is a rare, benign lung tumor. When encountering a well-defined solitary nodule with cystic spaces in the peripheral lung, an intraoperative diagnosis can be challenging. Therefore, it is critical to consider the possibility of AA, complete the surgery with a wedge resection and await the final pathological diagnosis.
Acknowledgements
Not applicable.
Funding
Funding: No funding was received.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Authors' contributions
HM was a major contributor to the conception of the study, as well as to the literature search for related studies. TU, NM, YT, TS and HH were involved in the literature review, and in the examination and interpretation of the patient's data. HM, KI, KT and TM were involved in the literature review, in the design of the study, in the critical revision of the manuscript and in the processing of the figures. KI and KT were the pathologists who performed the histopathological diagnosis of the patient. HM and TM confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.
Ethics approval and consent to participate
The patient provided written informed consent for participation.
Patient consent for publication
Written consent was obtained from the patient for the publication of his data and any related images.
Competing interests
The authors declare that they have no competing interests.
References
Yousem SA and Hochholzer L: Alveolar adenoma. Hum Pathol. 17:1066–1071. 1986.PubMed/NCBI View Article : Google Scholar | |
Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, Iersel CA, Bergh KAM, Westeinde SV, Aalst C, et al: Management of lung nodules detected by volume CT scanning. N Engl J Med. 361:2221–2229. 2009.PubMed/NCBI View Article : Google Scholar | |
MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, et al: Guidelines for management of incidental pulmonary nodules detected on CT Images: From the fleischner society 2017. Radiology. 284:228–243. 2017.PubMed/NCBI View Article : Google Scholar | |
Travis WD, Brambilla E, Burke AP, Marx A and Nicholson AG: Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 10:1240–1242. 2015.PubMed/NCBI View Article : Google Scholar | |
Bhavsar T, Uppal G, Travaline JM, Gaughan C, Huang Y and Khurana JS: An unusual case of a microscopic alveolar adenoma coexisting with lung carcinoma: A case report and review of the literature. J Med Case Rep. 5(187)2011.PubMed/NCBI View Article : Google Scholar | |
Sak SD, Koseoglu RD, Demirag F, Akbulut H and Gungor A: Alveolar adenoma of the lung. Immunohistochemical and flow cytometric characteristics of two new cases and a review of the literature. APMIS. 115:1443–1449. 2007.PubMed/NCBI View Article : Google Scholar | |
Hsieh MS, Tseng YH, Hua SF and Chou YH: Cystic alveolar adenoma: An unusual clinical presentation of a rare lung neoplasm. Pathology. 47:78–80. 2015.PubMed/NCBI View Article : Google Scholar | |
Burke LM, Rush WI, Khoor A, Mackay B, Oliveira P, Whitsett JA, Singh G, Turnicky R, Fleming MV, Koss MN and Travis WD: Alveolar adenoma: A histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. Hum Pathol. 30:158–1567. 1999.PubMed/NCBI View Article : Google Scholar | |
Wang L, Wang X, Rustam A and Hu J: Alveolar adenoma resected by thoracoscopic surgery. Ann Thorac Cardiovasc Surg. 19:489–491. 2013.PubMed/NCBI View Article : Google Scholar | |
Kondo N, Torii I, Hashimoto M, Takuwa T, Tanaka F, Tsujimura T and Hasegawa S: Alveolar adenoma of the lung: A case report. Ann Thorac Cardiovasc Surg. 17:71–73. 2011.PubMed/NCBI View Article : Google Scholar | |
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, et al: Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 399:1607–1617. 2022.PubMed/NCBI View Article : Google Scholar |